These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 26044127)
1. Urinary bladder urothelial carcinoma with concurrent plasmacytoid and micropapillary differentiations: A report of two cases with an emphasis on serum carbohydrate antigen 19-9. Makise N; Morikawa T; Takeshima Y; Fujimura T; Homma Y; Fukayama M Pathol Int; 2015 Sep; 65(9):495-500. PubMed ID: 26044127 [TBL] [Abstract][Full Text] [Related]
2. Transition between urothelial carcinoma in situ and non-invasive micropapillary carcinoma as a pivot connection between diverse morphologies of bladder carcinoma: a case report of urothelial carcinoma with villoglandular differentiation. Tajima S; Koda K Int J Clin Exp Pathol; 2015; 8(3):3288-93. PubMed ID: 26045854 [TBL] [Abstract][Full Text] [Related]
3. Large nested variant of urothelial carcinoma: 23 cases mimicking von Brunn nests and inverted growth pattern of noninvasive papillary urothelial carcinoma. Cox R; Epstein JI Am J Surg Pathol; 2011 Sep; 35(9):1337-42. PubMed ID: 21836490 [TBL] [Abstract][Full Text] [Related]
4. Plasmacytoid urothelial carcinoma of the bladder. Kohno T; Kitamura M; Akai H; Takaha M; Kawahara K; Oka T Int J Urol; 2006 Apr; 13(4):485-6. PubMed ID: 16734884 [TBL] [Abstract][Full Text] [Related]
5. Micropapillary urothelial carcinoma: an aggressive variant of urothelial carcinoma. Loghin A; Chibelean C; Orsolya M; Nechifor-Boilă A; Nechifor-Boilă A; Borda A Rom J Morphol Embryol; 2014; 55(3):939-45. PubMed ID: 25329124 [TBL] [Abstract][Full Text] [Related]
6. Clinical significance of prominent retraction clefts in invasive urothelial carcinoma. Shah TS; Kaag M; Raman JD; Chan W; Tran T; Kunchala S; Shuman L; DeGraff DJ; Chen G; Warrick JI Hum Pathol; 2017 Mar; 61():90-96. PubMed ID: 27818288 [TBL] [Abstract][Full Text] [Related]
7. Plasmacytoid variant of bladder cancer defines patients with poor prognosis if treated with cystectomy and adjuvant cisplatin-based chemotherapy. Keck B; Wach S; Stoehr R; Kunath F; Bertz S; Lehmann J; Stöckle M; Taubert H; Wullich B; Hartmann A BMC Cancer; 2013 Feb; 13():71. PubMed ID: 23394492 [TBL] [Abstract][Full Text] [Related]
8. Nuclear E-cadherin expression is associated with the loss of membranous E-cadherin, plasmacytoid differentiation and reduced overall survival in urothelial carcinoma of the bladder. Keck B; Wach S; Kunath F; Bertz S; Taubert H; Lehmann J; Stöckle M; Wullich B; Hartmann A Ann Surg Oncol; 2013 Jul; 20(7):2440-5. PubMed ID: 23108554 [TBL] [Abstract][Full Text] [Related]
10. Plasmacytoid variant urothelial bladder cancer: is it time to update the treatment paradigm? Kaimakliotis HZ; Monn MF; Cary KC; Pedrosa JA; Rice K; Masterson TA; Gardner TA; Hahn NM; Foster RS; Bihrle R; Cheng L; Koch MO Urol Oncol; 2014 Aug; 32(6):833-8. PubMed ID: 24954925 [TBL] [Abstract][Full Text] [Related]
11. E-cadherin expression in plasmacytoid, signet ring cell and micropapillary variants of urothelial carcinoma: comparison with usual-type high-grade urothelial carcinoma. Lim MG; Adsay NV; Grignon DJ; Osunkoya AO Mod Pathol; 2011 Feb; 24(2):241-7. PubMed ID: 20818341 [TBL] [Abstract][Full Text] [Related]
12. Cytological features of micropapillary and plasmacytoid variants of urothelial carcinoma. Straccia P; Martini M; Sacco E; Bassi PF; Pierconti F Diagn Cytopathol; 2020 Feb; 48(2):111-117. PubMed ID: 31650714 [TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical Differentiation of Plasmacytoid Urothelial Carcinoma From Secondary Carcinoma Involvement of the Bladder. Borhan WM; Cimino-Mathews AM; Montgomery EA; Epstein JI Am J Surg Pathol; 2017 Nov; 41(11):1570-1575. PubMed ID: 28786878 [TBL] [Abstract][Full Text] [Related]
15. Sarcomatoid variant of urothelial carcinoma of the urinary bladder. Bansal A; Kumar N; Sharma SC J Cancer Res Ther; 2013; 9(4):571-3. PubMed ID: 24518698 [TBL] [Abstract][Full Text] [Related]
16. Prognostic significance in substaging ofT1 urinary bladder urothelial carcinoma on transurethral resection. Chang WC; Chang YH; Pan CC Am J Surg Pathol; 2012 Mar; 36(3):454-61. PubMed ID: 22261706 [TBL] [Abstract][Full Text] [Related]
17. Urothelial Carcinoma In Situ of the Bladder With Glandular Differentiation: Report of 92 Cases. Yang Z; Epstein JI Am J Surg Pathol; 2018 Jul; 42(7):971-976. PubMed ID: 29683821 [TBL] [Abstract][Full Text] [Related]
18. Implications of micropapillary urothelial carcinoma variant on prognosis following radical cystectomy: A multi-institutional investigation. Mitra AP; Fairey AS; Skinner EC; Boorjian SA; Frank I; Schoenberg MP; Bivalacqua TJ; Hyndman ME; Reese AC; Steinberg GD; Large MC; Hulsbergen-van de Kaa CA; Bruins HM; Daneshmand S Urol Oncol; 2019 Jan; 37(1):48-56. PubMed ID: 30446450 [TBL] [Abstract][Full Text] [Related]
19. Urinary bladder urothelial carcinoma with expression of KIT and PDGFRA and showing diverse differentiations into plasmacytoid, clear cell, acantholytic, nested, and spindle variants, and into adenocarcinoma, signet-ring cell carcinoma, small cell carcinoma, large cell carcinoma, and pleomorphic carcinoma. Terada T Int J Clin Exp Pathol; 2013; 6(6):1150-6. PubMed ID: 23696935 [TBL] [Abstract][Full Text] [Related]
20. Plasmacytoid urothelial carcinoma of the bladder: a rare malignancy. Philippou P; Kariotis I; Volanis D; Ploumides A; Delakas D Urol Int; 2011; 86(3):370-2. PubMed ID: 21325783 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]